Biophytis SA

NASDAQ: BPTS trade with eToro - / - / France
1.05+0.0700+7.14%Vol 3241Y Perf -91.01%
Jun 28th, 2022 10:23 DELAYED
BID0.9800 ASK1.11
Open1.05 Previous Close0.9800
Pre-Market- After-Market-
 - -  - -%
Target Price
15.00 
Analyst Rating
Strong Buy 1.00
Potential %
1.33K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
1.09 
Earnings Rating
Market Cap15.49M 
Earnings Date
-
Alpha-0.15 Standard Deviation0.13
Beta0.74 

Today's Price Range

1.051.05

52W Range

0.940010.99

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-11.71%
1 Month
-22.83%
3 Months
-63.97%
6 Months
-81.19%
1 Year
-91.01%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BPTS1.050.07007.14
AAPL137.44-4.2200-2.98
GOOG2 251.43-81.0200-3.47
MSFT256.48-8.4100-3.17
XOM91.502.47002.77
WFC40.18-0.0600-0.15
JNJ176.94-5.1800-2.84
FB196.640.99000.51
GE65.88-0.8300-1.24
JPM115.82-0.5600-0.48
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume324
Shares Outstanding14.75K
Shares Float14.75M
Trades Count5
Dollar Volume347
Avg. Volume6.41K
Avg. Weekly Volume2.13K
Avg. Monthly Volume3.64K
Avg. Quarterly Volume13.47K

Biophytis SA (NASDAQ: BPTS) stock closed at 0.98 per share at the end of the most recent trading day (a -9.26% change compared to the prior day closing price) with a volume of 271.0000 shares and market capitalization of 15.49M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the industry, sector and employs 31 people. Biophytis SA CEO is .

The one-year performance of Biophytis SA stock is -91.01%, while year-to-date (YTD) performance is -81.65%. BPTS stock has a five-year performance of %. Its 52-week range is between 0.94 and 10.9901, which gives BPTS stock a 52-week price range ratio of 1.09%

Biophytis SA currently has a PE ratio of -0.40, a price-to-book (PB) ratio of 2.38, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -98.46%, a ROC of -153.04% and a ROE of -777.65%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Biophytis SA, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Biophytis SA’s next earnings report date is -.

The consensus rating of Wall Street analysts for Biophytis SA is Strong Buy (1), with a target price of $15, which is +1 328.57% compared to the current price. The earnings rating for Biophytis SA stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Biophytis SA has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Biophytis SA has a Sell technical analysis rating based on Technical Indicators (ADX : 42.69, ATR14 : 0.20, CCI20 : -140.72, Chaikin Money Flow : -0.30, MACD : -0.16, Money Flow Index : 59.11, ROC : -24.03, RSI : 37.33, STOCH (14,3) : 6.67, STOCH RSI : 0.21, UO : 33.04, Williams %R : -93.33), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Biophytis SA in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Biophytis SA

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.

CEO:

Telephone: +33 144272300

Address: 4 place Jussieu, Paris 75252, , FR

Number of employees: 31

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

55%45%

Bearish Bullish

50%50%

News

Stocktwits